An electrochemical biosensor based on DNA tetrahedron/graphene composite film for highly sensitive detection of NADH

Biosensors & Bioelectronics
Zonglin LiXianting Ding

Abstract

Dihydronicotinamide adenine dinucleotide (NADH) is a major biomarker correlated with lethal diseases such as cancers and bacterial infection. Herein, we report a graphene-DNA tetrahedron-gold nanoparticle modified gold disk electrode for highly sensitive NADH detection. By assembling the DNA tetrahedron/graphene composite film on the gold disk electrode surface which prior harnessed electrochemical deposition of gold nanoparticles to enhance the effective surface area, the oxidation potential of NADH was substantially decreased to 0.28V (vs. Ag/AgCl) and surface fouling effects were successfully eliminated. Furthermore, the lower detection limit of NADH by the presented platform was reduced down to 1fM, with an upper limit of 10pM. Both the regeneration and selectivity of composite film-modified electrode are investigated and proved to be robust. The novel sensor developed here could serve as a highly sensitive probe for NADH detection, which would further benefit the field of NADH related disease diagnostics.

Citations

Nov 16, 2016·IEEE Transactions on Nanobioscience·W SuXianting Ding
Dec 20, 2015·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Yu ZhangLianhui Wang
Jun 3, 2018·International Journal of Molecular Sciences·Clara I ColinoJosé M Lanao
Apr 8, 2020·Science China. Life Sciences·Fan LiChunhai Fan
Jun 3, 2021·Analytical Methods : Advancing Methods and Applications·Ding ShenSuqing Zhao
May 4, 2018·ACS Sensors·Fan YangChunhai Fan
Jan 4, 2019·Chemical Reviews·Zheng MengKatherine A Mirica

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.